News & Updates

Show Multimedia Only

Original New Drug Application Approvals by US FDA (15-30 September 2023)

10 Oct 2023

New drug applications approved by US FDA as of 15-30 September 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (15-30 September 2023)

10 Oct 2023

H pylori a usual finding during endoscopy for other paediatric GI diseases

09 Oct 2023

A common incidental discovery during upper endoscopy for the diagnosis of common paediatric gastrointestinal (GI) diseases is Helicobacter pylori (H pylori) gastritis, a recent study has revealed. However, indications for treatment are not clear and warrant further research.

H pylori a usual finding during endoscopy for other paediatric GI diseases

09 Oct 2023

COVID vs non-COVID ARDS: Are both mentally distressing for patients’ kin?

04 Oct 2023 by

Mental health symptoms of family members of patients hospitalized for acute respiratory distress syndrome (ARDS) were similar at 12 months regardless of whether it was caused by COVID-19 or not, a prospective cohort study suggests.

COVID vs non-COVID ARDS: Are both mentally distressing for patients’ kin?

04 Oct 2023

Heavy alcohol use among hepatitis C patients does not weaken response to DAAs

03 Oct 2023 by

Among patients with hepatitis C virus (HCV) infection, the likelihood of achieving sustained virologic response (SVR) with direct-acting antivirals (DAAs) does not appear to be reduced among those who use alcohol or have alcohol use disorder (AUD), according to a study.

Heavy alcohol use among hepatitis C patients does not weaken response to DAAs

03 Oct 2023

Do alpha-1 receptor blockers prevent severe COVID-19?

03 Oct 2023

Frequent use of alpha-1 receptor blockers neither increases nor reduces the risk of uncomplicated or severe COVID-19 hospitalization in older men with or without benign prostatic hyperplasia (BPH), reveals a recent study.

Do alpha-1 receptor blockers prevent severe COVID-19?

03 Oct 2023

Nirmatrelvir, molnupiravir effective against Omicron in high-risk patients

02 Oct 2023 by

Treatment with either nirmatrelvir or molnupiravir helps reduce mortality and hospitalization in COVID-19 patients infected with the Omicron variant and are at high-risk of progressing to severe disease, as shown in a study.

Nirmatrelvir, molnupiravir effective against Omicron in high-risk patients

02 Oct 2023

Magnetic hydrogel micromachines eradicate biofilms in tubular implants

29 Sep 2023 by

Researchers from the Chinese University of Hong Kong (CUHK) have developed magnetic hydrogel micromachines with active release of antibacterial agents for biofilm eradication in small tubular medical implants.

Magnetic hydrogel micromachines eradicate biofilms in tubular implants

29 Sep 2023

Liver cirrhosis tied to higher risk of herpes zoster

26 Sep 2023

The risk of herpes zoster (HZ) and HZ-related hospitalization is much higher among patients with liver cirrhosis (LC), especially those who are not currently recommended for HZ vaccination, than the general population, according to a nationwide population-based study in Korea.